Therapist-designed apps emerge

Two new mental health apps are pitching a familiar promise with a sharper label: therapist-designed tools and artificial intelligence that turns daily check-ins into patterns people can act on. The launches land in a market where clinicians and health systems still sort apps by privacy, evidence, and whether patients keep using them. (apps.apple.com) (psychiatry.org) MindWeave’s iPhone app says it combines journaling, mood tracking, Apple Health data, and an artificial-intelligence coach to surface links among mood, sleep, steps, heart-rate variability, and habits. Its App Store listing says the app is free to start, includes five AI coach messages a day and three AI analyses a week, and offers weekly correlation summaries. (apps.apple.com) The company’s website also markets MindWeave as an attention-deficit/hyperactivity disorder support app with focus tools, cognitive behavioral therapy lessons, mood tracking, and an AI companion. That puts it in a broad class of apps trying to keep people engaged between therapy sessions or before they ever see a clinician. (mindweaveapp.com) (nature.com) CoreShift is using a different pitch. Its site says the company is built around “Work Day Awareness,” a proprietary framework for understanding how energy shapes engagement, decision-making, and performance, and says its advisory group includes people from organizational psychology, leadership strategy, employee engagement, and systems thinking. (coreshift.com) What counts as “clinically backed” in this category varies widely. The American Psychiatric Association’s app evaluation model tells clinicians to look first at privacy and safety, then evidence, engagement, and whether an app fits a patient’s needs, rather than treating marketing language as proof on its own. (psychiatry.org) That caution reflects the research record. A 2025 meta-analysis in *npj Digital Medicine* reviewed 92 randomized trials with 16,728 participants and found digital mental health apps can help, but outcomes depend heavily on design and user engagement. (nature.com) Another 2025 review in *The Lancet Digital Health* described the evidence for standalone mental health apps as still inconclusive overall, even as trials continue to expand. A separate 2025 meta-analysis in *JAMA Psychiatry* found adherence and attrition remain central problems in depression and anxiety app studies. (thelancet.com) (jamanetwork.com) Health systems and regulators have been building checklists to deal with that gap between product claims and proof. The National Institute for Health and Care Excellence in the United Kingdom says digital health tools should be judged against evidence standards tied to their risk and intended use, not treated as interchangeable wellness products. (nice.org.uk) For users, that means the practical questions are still basic ones: what data the app collects, whether it encrypts journal entries, what health signals it reads, and whether any published research matches the feature being sold. MindWeave says journal entries are encrypted with AES-256 and that it does not sell user data; its App Store privacy label also says health and fitness data, purchases, user content, identifiers, and usage data may be linked to identity. (apps.apple.com) The near-term test for both products is not whether they can describe mood or purpose in cleaner language. It is whether they can show patients, therapists, employers, or health systems that people actually use them — and that the results hold up outside the app store page. (psychiatry.org) (nature.com)